BackDate of JudgmentMay 12, 2022Issuing AuthorityIntellectual Property High Court of KoreaLevel of the Issuing AuthorityFirst InstanceType of ProcedureJudicial (Administrative)Subject MatterPatents (Inventions)Plaintiff/AppellantA (China)Defendant/RespondentCommissioner of the Korean Intellectual Property Office Keywords
Rejection,
Divisional application,
Pharmaceutical composition,
Pharmaceutical use invention,
IC50,
Description requirement of a specification,
Pharmacological mechanism,
Peramivir
Judgment/DecisionEnglishIP High Court Decision, 2021Heo3758, dated May 12, 2022 PDFKorean특허법원 2022. 5. 12 선고 2021허3758판결 PDFRelevant Legislation